Webinar: ACR/CHEST ILD Guidelines in Practice| Video: All the Lonely People

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Guidance

Subcategories:Clinical Criteria/GuidelinesEthicsLegal UpdatesLegislation & AdvocacyMeeting ReportsResearch Rheum

Figure 2: High-resolution computed tomography showed evidence of interstitial lung disease.

High-resolution computed tomography shows evidence of ILD.

The ACR/CHEST ILD Guidelines in Practice, a video
In collaboration with the American College of Chest Physicians, the ACR released two new comprehensive guidelines aimed at improving the screening, monitoring, and treatment of patients with interstitial lung disease (ILD) secondary to systemic autoimmune rheumatic diseases (SARDs). Recently, Sindhu R. Johnson, MD, PhD, professor of medicine at the University of Toronto, Canada, director of the Toronto Scleroderma Program and principal investigator for the guideline, and Elana J. Bernstein, MD, MSc, Florence Irving associate professor of medicine in the Division of Rheumatology at Columbia University, New York City, and co-first author, presented a webinar to talk about how the guidelines were developed and present some of the recommendations and their rationale: Watch the recording now!

 

Bridge Funding Award Keeps Researcher on the Path to Her Passion

  |  

On June 25, 2008, the American College of Rheumatology Research and Education Foundation received a letter from Sujata Sarkar, MD, one of the first recipients of the ACR REF/Arthritis Foundation Bridge Funding Award. In that letter Dr. Sarkar wrote, “I am very thankful to you … This award has come to me at a very crucial and vulnerable time in my academic career as a junior researcher.” The crucial and vulnerable time to which Dr. Sarkar refers is the time when she would need to search for alternative funding to pay for her rheumatology research career—or leave academia altogether.

I Am an Advocate

Charles King, MD  |  

It was the best of times, it was the worst of times; it was the age of wisdom, it was the age of foolishness.” Cliché perhaps, but certainly fitting in describing the practice of rheumatology of late. We have been blessed with a widening array of therapies with which to treat rheumatologic illnesses. The advent of the biological era promises even greater potential for meaningful reductions in disability and death from these diseases.

An American in Paris

David S. Pisetsky, MD, PhD  |  

Visiting a historical city inspires reflections on the history and progress of rheumatology

Rheum to Learn

Terry Hartnett  |  

The ARHP’s new NP/PA rheumatology training program will provide a boost to the workforce